In a similar way to patents, the registration number of designs will now align with the nine digit application number.

Advice on the significant changes and developments in transfer pricing over the past 12 months.

This report describes corporate benefits from when expert input is sought from people from a broad range of backgrounds.

Our colleagues have examined last night's budget and explored its impact and what it means for companies.

Article notes & provides link to recent patent law decision where Commonwealth lost its claim for damages & link to previous article.

This article discusses the three main reasons why patent specifications are complex to draft.

In the resources sector, where innovation could provide key competitive advantages, a strong IP strategy is often vital.

The article uses an example to illustrate the process of developing an invention, from concept to commercialisation.

This is a selection of the more interesting trademark cases for 2019, with an indication of the types of issues covered.

These proposed changes will impact on how Australia capitalises on its innovation strategy and competitive position.

With the end of financial year approaching, are you getting the most out of your Export Market Development Grant?

Welcome to Shelston IP's round up of some of the best Australian and New Zealand trade mark cases for 2020.

Welcome to Shelston IP's round-up of the best and most significant patent cases from Australia delivered during 2016.

This articles discusses recent significant decisions, interlocutory applications for injunctions and various other orders. .

IP Australia provides free extensions of time of up to three months, if a deadline cannot be met because of COVID-19.

Examination of OECD guidelines related to intangibles & IP, including entitlement of the legal owner to the associated profits.

A long awaited Australian Senate committee report into gene patenting has recently been released, providing totally inconclusive results, meaning the status quo on gene patents is maintained for now. The terms of reference for the inquiry directed the Committee to consider the impacts of gene patents on healthcare, medical research and the health and wellbeing of Australians.

A Principal from Shelston IP discusses the current issues surrounding patent law and the pharmaceutical industry.

IP Australia provides a streamlined process for requesting an extension of time for delays caused by the COVID-19 crisis.

Following from the recent political partisanship in the US there has been a shutdown of non-essential government services.